VItamin D Metabolism in SEnescent Cardiac Surgery Patients (VISE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01378221 |
|
Recruitment Status :
Completed
First Posted : June 22, 2011
Results First Posted : January 30, 2014
Last Update Posted : January 30, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Coronary Artery Bypass Grafting Heart Valve Surgery |
| Study Type : | Observational |
| Actual Enrollment : | 75 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Vitamin D Metabolism in Senescent Cardiac Surgery Patients |
| Study Start Date : | September 2009 |
| Actual Primary Completion Date : | February 2011 |
| Actual Study Completion Date : | May 2011 |
| Group/Cohort |
|---|
|
Group 1
cardiac surgery patients age 65 years and less
|
|
Group 2
cardiac surgery patients aged 75 years and over
|
- Peri- and Postoperative Time Course of Circulating 1,25-dihydroxyvitamin D in the First Postoperative Month in Cardiac Surgery Patients [ Time Frame: change from baseline within 1 month after cardiac surgery ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- age: <= 65 years and >= 75 years
- first elective cardiac surgery (bypass or combined bypass and heart valve surgery)
- written informed consent
Exclusion Criteria:
- emergency cardiac intervention
- primary hyperparathyreoidism
- primary and secondary hypoparathyreoidism
- daily vitamin D supplementation > 10 micrograms
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01378221
| Germany | |
| Heart Center North Rhine-Westphalia | |
| Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545 | |
| Principal Investigator: | Jochen Börgermann, MD | Heart Center NRW, Ruhr University Bochum, 32545 Bad Oeynhausen, Germany |
| Responsible Party: | Heart and Diabetes Center North-Rhine Westfalia |
| ClinicalTrials.gov Identifier: | NCT01378221 |
| Other Study ID Numbers: |
005 |
| First Posted: | June 22, 2011 Key Record Dates |
| Results First Posted: | January 30, 2014 |
| Last Update Posted: | January 30, 2014 |
| Last Verified: | December 2013 |
|
vitamin D cardiac surgery inflammation immune system age |

